Skip to content

Clinical trials

Thalassemia trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20131
20152
20162
20172
20183
20201
20221
20245
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Active, not recruiting2
Recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hangzhou Zede Pharma-Tech Co., Ltd.4
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine3
Novartis Pharmaceuticals3
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine2
Xiao-Lin Yin2
First Affiliated Hospital of Guangxi Medical University1
Institute of Hematology & Blood Diseases Hospital, China1
Novo Nordisk A/S1
Reproductive & Genetic Hospital of CITIC-Xiangya1
ScinnoHub Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia21
Anemia3
Iron Overload3
Anemia, Diamond-Blackfan2
Graft vs Host Disease2
Myelodysplastic Syndromes2
beta-Thalassemia2
Anemia, Hemolytic1
Anemia, Hemolytic, Congenital1
Anemia, Sickle Cell1

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.